Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Istradefylline Study in Parkinson's Disease
NCT02610231Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of Istradefylline in Parkinson's disease (PD), sponsored by Kyowa Kirin. Started Dec 2015; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02610231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610231.